PRP Therapy for Alopecia After Breast Cancer Treatment
What You Need to Know Before You Apply
What is the purpose of this trial?
Participants who enroll in this study will undergo the platelet-rich plasma (PRP) study treatment. Participants will have a sample of blood collected and the platelets will be separated and then injected into half of the participants' scalp every 4 weeks for 12 weeks.
Will I have to stop taking my current medications?
You may need to stop certain medications before joining the trial. If you've used topical minoxidil or spironolactone for hair loss, you'll need a 3-month break before starting. Also, if you're taking aspirin, NSAIDs, or fish-oil supplements, you'll need to stop them 7 days before treatment.
Is PRP therapy generally safe for humans?
How is PRP treatment different from other treatments for alopecia after breast cancer?
PRP treatment is unique because it uses a concentration of platelets from the patient's own blood to promote hair growth, making it a natural and minimally invasive option compared to other treatments. It is administered through injections and is considered safe and effective for various types of hair loss, including those not typically addressed by standard treatments.12367
Who Is on the Research Team?
Anthony Rossi, MD
Principal Investigator
Memorial Sloan Kettering Cancer Center
Are You a Good Fit for This Trial?
This trial is for women over 18 with hair loss after breast cancer treatment, who haven't used endocrine therapy in the last 6 months or certain alopecia treatments without a 3-month break. It's not for those pregnant, breastfeeding, with scalp conditions, past hair transplants, taking anticoagulants (unless stopped a week before), or on fish oil/NSAIDs without pausing them.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo platelet-rich plasma (PRP) treatment with injections into the scalp every 4 weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- PRP Treatment
PRP Treatment is already approved in United States, Canada, European Union for the following indications:
Find a Clinic Near You
Who Is Running the Clinical Trial?
Memorial Sloan Kettering Cancer Center
Lead Sponsor